MedPath

A Comparative Clinical Study Of Punarnavadi Arka Eye Drops With Punarnava Arka Eye Drops In Allergic Conjunctivitis

Phase 2
Conditions
Health Condition 1: H109- Unspecified conjunctivitis
Registration Number
CTRI/2024/07/070915
Lead Sponsor
Dr Suchetha Jayaram
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects presenting with lakshanas of kaphaja abhisyanda

Subjects presenting with clinical features of allergic conjunctivitis

Subjects within the age group of 20 to 60 years irrespective of gender

Exclusion Criteria

Subjects with history of phlyctenular conjunctivitis Giant papillary conjunctivitis Contact dermatoconjunctivitis and toxic conjunctivitis

Subjects with history of allergic conjunctivitis associated with dacryocystitis and other ocular diseases and conjunctivitis complicated with corneal ulcers

Subjects with history of allergic conjunctivitis due to systemic and autoimmune diseases

Subjects with history of systemic diseases that interfere with the course of study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To see the rate of healing of ulcer redness lalasrava ruja burning sensation by giving Triphala Kashaya kavalagraha and Pippalyadi Kashaya in the management of mukhapaka wsr Aphthous ulcerTimepoint: total duration of study is 21 days seka and eye drops will be given for 7 days eye drops will be continued for next 7 days followup after 1 week
Secondary Outcome Measures
NameTimeMethod
nillTimepoint: not applicable
© Copyright 2025. All Rights Reserved by MedPath